Last reviewed · How we verify

NCT07203560

Effect of Neurodynamic Mobilization in Patients With Lumbar Disc Herniation

Completed NA Last updated 2 October 2025
What this trial tests

NA trial testing Neurodynamic Mobilization in Lumbar Disc Herniation in 40 participants. Completed in 10 May 2019.

Timeline
4 June 2018
Primary endpoint
10 May 2019
10 May 2019

Quick facts

Lead sponsorAydin Adnan Menderes University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date4 June 2018
Primary completion10 May 2019
Estimated completion10 May 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 20 to 60, any sex, with Lumbar Disc Herniation or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized controlled trial was to investigate the effects of neurodynamic mobilization on pain intensity, normal joint motion, neurodynamics, functional level, and disability in patients with lumbar disc herniation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Neurodynamic Mobilization

Trials testing the same drug.

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07203560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing